Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
12 pending office actions • 8 art units • 12 examiners • 0 of 12 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
Georgia State University Research Foundation Inc. maintains 12 pending office actions in the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 12 distinct examiners, creating a ratio of 12 pending actions to 12 examiners. The portfolio involves 8 distinct art units, suggesting that the research foundation's intellectual property spans multiple specialized examination groups within the biotechnology sector.
MOSHER, ERIC PARKER is identified as the busiest examiner, though this individual is responsible for 1 pending office action. This distribution indicates that no examiner holds a disproportionate share of the pending workload. The presence of 8 art units reflects a diverse prosecution landscape where legal strategies must account for the varying standards of multiple USPTO divisions. Practitioners should prepare for a wide range of examiner behaviors, as the high number of distinct examiners relative to the total pending actions limits the ability to predict outcomes based on 1 individual's history. Managing the separate examiners across the 8 art units requires a highly organized approach to ensure consistent claim construction.
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (8%) |
| §103 only | 2 (17%) |
| Double-patenting only | 1 (8%) |
| Double-patenting + other | 3 (25%) |
| Multi-statute (no §101) | 5 (42%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MOSHER, ERIC PARKER | 1 | 100.0% | +0.0% |
| SAMALA, JAGADISHWAR RAO | 1 | 68.0% | +55.6% |
| MCCALL SHEPARD, SONYA D | 1 | 92.8% | +3.5% |
| VALENROD, YEVGENY | 1 | 72.6% | +25.1% |
| CHANDRAKUMAR, NIZAL S | 1 | 72.7% | +18.3% |
| BORI, IBRAHIM D | 1 | 43.8% | +38.9% |
| BULLINGTON, ROBERT P | 1 | 42.7% | +30.3% |
| DONOHUE, SEAN R | 1 | 41.4% | +21.0% |
| SWIFT, CANDICE LEE | 1 | 57.5% | +36.0% |
| CANDELARIA, JULIANA IRENE | 1 | 0.0% | +0.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18834839 | RED-SHIFTED FLUOROPHORES AND METHODS OF USING THE SAME | MOSHER, ERIC PARKER | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17996573 | SIRPa Deficient Macrophages for Treating Cancer | CANDELARIA, JULIANA IRENE | 32d overdue |
| 18123236 | Small Molecule Ligand-Drug Conjugates for Targeted Cancer Therapy | DONOHUE, SEAN R | 2d overdue |
| 18551277 | Systems and Methods for Predicting Behavioral Traits | BULLINGTON, ROBERT P | 1d overdue |
| 17610892 | SENSORS AND METHODS USING ELECTROCHEMILUMINESCENCE OF METAL NANOCLUSTERS | DICKINSON, PAUL W | 12d |
| 18730243 | PH-SENSITIVE FLUOROPHORES | SAMALA, JAGADISHWAR RAO | — |
| 18714464 | FLEXIBLE AND MINIATURIZED COMPACT VERTICAL COLOR SENSOR | MCCALL SHEPARD, SONYA D | — |
| 18286191 | GRAPHENE OXIDE NANOPARTICLES AND METHODS OF USE FOR STIMULATING IMMUNE RESPONSES | BORI, IBRAHIM D | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18123236 | Small Molecule Ligand-Drug Conjugates for Targeted Cancer Therapy | DONOHUE, SEAN R | 2d overdue |
| 18551277 | Systems and Methods for Predicting Behavioral Traits | BULLINGTON, ROBERT P | 1d overdue |
| 18730243 | PH-SENSITIVE FLUOROPHORES | SAMALA, JAGADISHWAR RAO | — |
| 18682755 | BICYCLIC FUSED PYRAZOLE DERIVATIVES FOR THE TREATMENT OF RESPIRATORY INFECTIONS INCLUDING RSV | VALENROD, YEVGENY | — |
| 18577529 | THE USE OF BETA-HYDROXYBUTYRATES FOR THE TREATMENT OR PREVENTION OF ANEURYSMS AND DISSECTIONS | CHANDRAKUMAR, NIZAL S | — |
| 18286191 | GRAPHENE OXIDE NANOPARTICLES AND METHODS OF USE FOR STIMULATING IMMUNE RESPONSES | BORI, IBRAHIM D | — |
| 18012252 | PLASTIC POLYMER BIOCONVERSION PROCESS | SWIFT, CANDICE LEE | — |
| Art Unit | Apps |
|---|---|
| 1618 | 2 |
| 1628 | 1 |
| 1625 | 1 |
| 1629 | 1 |
| 3715 | 1 |
| 1657 | 1 |
| 1634 | 1 |
| 1637 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18834839 | RED-SHIFTED FLUOROPHORES AND METHODS OF USING THE SAME | MOSHER, ERIC PARKER | — | §102§103§112DP | Non-Final OA | — | Pending | Jul 31, 2024 |
| 18730243 | PH-SENSITIVE FLUOROPHORES | SAMALA, JAGADISHWAR RAO | — | §102§103 | Non-Final OA | — | Pending | Jul 18, 2024 |
| 18714464 | FLEXIBLE AND MINIATURIZED COMPACT VERTICAL COLOR SENSOR | MCCALL SHEPARD, SONYA D | — | §102§103 | Non-Final OA | — | Pending | May 29, 2024 |
| 18682755 | BICYCLIC FUSED PYRAZOLE DERIVATIVES FOR THE TREATMENT OF RESPIRATORY INFECTIONS INCLUDING RSV | VALENROD, YEVGENY | 1628 | §102§103§112DP | Non-Final OA | — | Pending | Feb 09, 2024 |
| 18577529 | THE USE OF BETA-HYDROXYBUTYRATES FOR THE TREATMENT OR PREVENTION OF ANEURYSMS AND DISSECTIONS | CHANDRAKUMAR, NIZAL S | 1625 | §103 | Non-Final OA | — | Pending | Jan 08, 2024 |
| 18286191 | GRAPHENE OXIDE NANOPARTICLES AND METHODS OF USE FOR STIMULATING IMMUNE RESPONSES | BORI, IBRAHIM D | 1629 | §102§103 | Non-Final OA | — | Pending | Oct 09, 2023 |
| 18551277 | Systems and Methods for Predicting Behavioral Traits | BULLINGTON, ROBERT P | 3715 | §101§112 | Final Rejection | 1d overdue | Pending | Sep 19, 2023 |
| 18123236 | Small Molecule Ligand-Drug Conjugates for Targeted Cancer Therapy | DONOHUE, SEAN R | 1618 | §103§112 | Non-Final OA | 2d overdue | Pending | Mar 17, 2023 |
| 18012252 | PLASTIC POLYMER BIOCONVERSION PROCESS | SWIFT, CANDICE LEE | 1657 | §103§112DP | Final Rejection | — | Pending | Dec 22, 2022 |
| 17996573 | SIRPa Deficient Macrophages for Treating Cancer | CANDELARIA, JULIANA IRENE | 1634 | DP | Final Rejection | 32d overdue | Pending | Oct 19, 2022 |
| 17610892 | SENSORS AND METHODS USING ELECTROCHEMILUMINESCENCE OF METAL NANOCLUSTERS | DICKINSON, PAUL W | 1618 | §103§112 | Final Rejection | 12d | Pending | Nov 12, 2021 |
| 17315987 | METHODS FOR GENERATING MACROPHAGES WITH ENHANCED CANCER PHAGOCYTOSIS | ANGELL, JON E | 1637 | §103 | Final Rejection | 17d overdue | Pending | May 10, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial